2016
DOI: 10.1039/c6md00229c
|View full text |Cite
|
Sign up to set email alerts
|

A natural product inspired fragment-based approach towards the development of novel anti-bacterial agents

Abstract: The discovery of new antibiotics with novel modes of action to combat antimicrobial resistance (AMR) is of vital importance. The natural product simocyclinone D8 (SD8) is a potent inhibitor of DNA gyrase. Its bi-functional structure and novel mode of action serve as an inspiring lead for antibiotic development. Herein we describe a proof of principle fragment-based approach towards the development of a new class of coumarin-quinolone hybrids. We demonstrate that the coumarin moiety is required for the observed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 28 publications
(25 reference statements)
0
7
0
Order By: Relevance
“…The coumarin moiety proved necessary for the observed inhibitory activity (IC 50 ~3 µM) of the hybrid compound, which is in part mediated by stabilization of a cleaved-DNA intermediate. 69…”
Section: New Structures For Old Molecular Targets: “A Good Target Is mentioning
confidence: 99%
See 1 more Smart Citation
“…The coumarin moiety proved necessary for the observed inhibitory activity (IC 50 ~3 µM) of the hybrid compound, which is in part mediated by stabilization of a cleaved-DNA intermediate. 69…”
Section: New Structures For Old Molecular Targets: “A Good Target Is mentioning
confidence: 99%
“…The coumarin moiety proved necessary for the observed inhibitory activity (IC 50 ~3 µM) of the hybrid compound, which is in part mediated by stabilization of a cleaved-DNA intermediate. 69 The type II fatty acid biosynthetic pathway is an excellent target for antibacterial drug discovery. 70 A Pfizer research group described pyridopyrimidine-based potent biotin carboxylase inhibitors using the FBLG approach.…”
Section: Fragment-based Drug Discoverymentioning
confidence: 99%
“…NP-derived fragments can be highly different from synthetic compounds, when structural features, design, and obtention of a library component are compared. (Genis, Kirpichenok, Kombarov, 2012;Austin et al, 2016;Over et al, 2012;Pascolutii et al, 2015;Prescher et al, 2017;Rodrigues et al, 2016).…”
Section: Natural Product-derived Fragmentsmentioning
confidence: 99%
“…Recently, the Searcey group developed a hybrid of the high-molecular weight simocyclinone D8 with ciprofloxacin, using a spacer to link the antibiotic to the coumarin core inspired by the NP structure ( Figure 7). (Austin et al, 2016).…”
Section: B) Natural Product-based Fragmentsmentioning
confidence: 99%
“…To this end, a series of ciprofloxacin-aminocoumarin hybrids has been synthesized, designed to bind to the aminocoumarin pocket of SD8 and to the fluoroquinolone pocket (Austin et al . 2016 ); some of these compounds retain good inhibitory activity against gyrase. It remains to be seen whether such compounds can be developed as viable antibiotics.…”
Section: Simocyclinones As Antibioticsmentioning
confidence: 99%